(19)
(11) EP 4 824 092 A1

(12)

(43) Date of publication:
21.10.2026 Bulletin 2026/43

(21) Application number: 24828774.0

(22) Date of filing: 12.12.2024
(51) International Patent Classification (IPC): 
C07K 16/28(2006.01)
A61P 35/00(2006.01)
(52) Cooperative Patent Classification (CPC):
C07K 16/2827; A61K 2039/505; A61K 2039/507; C07K 2317/76; C07K 2317/24; A61P 35/00
(86) International application number:
PCT/EP2024/086033
(87) International publication number:
WO 2025/125495 (19.06.2025 Gazette 2025/25)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
GE KH MA MD TN

(30) Priority: 13.12.2023 US 202363609552 P
29.02.2024 US 202463559469 P

(71) Applicant: Hummingbird Bioscience Pte. Ltd.
Singapore 117586 (SG)

(72) Inventors:
  • DHARMADHIKARI, Bhushan
    Singapore 117586 (SG)
  • ZHARKOVA, Olga
    Singapore 117586 (SG)
  • TIRADO-MAGALLANES, Roberto
    Singapore 117586 (SG)
  • THAKKAR, Dipti
    Singapore 117586 (SG)
  • PASZKIEWICZ, Konrad
    Singapore 117586 (SG)
  • BOYD-KIRKUP, Jerome Douglas
    Singapore 117586 (SG)
  • INGRAM, Piers
    Singapore 117586 (SG)

(74) Representative: Roukounas, Dimitrios 
c/o Regus Business Center Nymphenburger Straße 4
80335 München
80335 München (DE)

   


(54) TREATMENT AND PREVENTION OF CANCER USING VISTA ANTIGEN-BINDING MOLECULES